Quantify any protein, in any sample, with any modification, without antibodies
Target Sufficiency® enables direct, quantitative analysis of drug target systems in cells, biofluids, tissues, and tissue models, including formalin-fixed, paraffin-embedded (FFPE) tissues.
Inotiv provides the broadest range of research models and related services to pharmaceutical and biotech companies, government, academia, and other life science organizations.
Tuesday, January 21, 2025 San Diego, CA 9:00 am-5:00 pm Biocom California, 10996 Torreyana Rd A full day dedicated to knowledge-sharing about Göttingen Minipigs in biomedical re...
Thursday, January 23, 2025 South San Francisco, CA 9:00 am-5:00 pm AC Hotel San Francisco Airport/Oyster Point Waterfront, 1333 Veterans Blvd A full day dedicated to knowledge-s...
Tuesday, February 11, 2025 Webinar 11:00 am EST Compassion fatigue is a prevalent issue that poses significant challenges to the well-being of lab animal science professionals. Rec...
December 30, 2024 WEST LAFAYETTE, Ind., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization...
December 23, 2024 WEST LAFAYETTE, Ind., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization...
Due to the current FDA concern and guidance on reducing the risk of Nitrosamine impurities in human drugs, there has been an increased industry need for testing of these impurities using the Bacterial Reverse Mutation (Ames) test. As Nitrosamines are not readily detectable by standard Ames methodologies, specifically cited in the Ames testing guideline (OECD 471), the need for a robust protocol better suited for this class of compounds is warranted.
General Toxicology
Histology
Pathology
DMPK
Consulting
Research Models
Research Model Services
Teklad Diet and Bedding
